ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development

Y Hee Choi, AM Yu - Current pharmaceutical design, 2014 - ingentaconnect.com
Multidrug resistance (MDR) is a serious problem that hampers the success of cancer
pharmacotherapy. A common mechanism is the overexpression of ATP-binding cassette …

Glioma: experimental models and reality

K Lenting, R Verhaak, M Ter Laan, P Wesseling… - Acta …, 2017 - Springer
In theory, in vitro and in vivo models for human gliomas have great potential to not only
enhance our understanding of glioma biology, but also to facilitate the development of novel …

Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors

Y Uchida, S Ohtsuki, Y Katsukura… - Journal of …, 2011 - Wiley Online Library
J. Neurochem.(2011) 117, 333–345. Abstract We have obtained, for the first time, a
quantitative protein expression profile of membrane transporters and receptors in human …

ABC multidrug transporters: structure, function and role in chemoresistance

FJ Sharom - Pharmacogenomics, 2008 - Taylor & Francis
Three ATP-binding cassette (ABC)-superfamily multidrug efflux pumps are known to be
responsible for chemoresistance; P-glycoprotein (ABCB1), MRP1 (ABCC1) and ABCG2 …

Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma

RK Oberoi, KE Parrish, TT Sio, RK Mittapalli… - Neuro …, 2015 - academic.oup.com
Glioblastoma (GBM) is a lethal and aggressive brain tumor that is resistant to conventional
radiation and cytotoxic chemotherapies. Molecularly targeted agents hold great promise in …

Recent advances in drug delivery and targeting to the brain

B Sethi, V Kumar, K Mahato, DW Coulter… - Journal of Controlled …, 2022 - Elsevier
Our body keeps separating the toxic chemicals in the blood from the brain. A significant
number of drugs do not enter the central nervous system (CNS) due to the blood-brain …

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

K Natarajan, Y Xie, MR Baer, DD Ross - Biochemical pharmacology, 2012 - Elsevier
Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance
protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter …

Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system

B Sarkadi, L Homolya, G Szakács… - Physiological …, 2006 - journals.physiology.org
In this review we give an overview of the physiological functions of a group of ATP binding
cassette (ABC) transporter proteins, which were discovered, and still referred to, as …

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

JF Deeken, W Löscher - Clinical cancer research, 2007 - AACR
Despite scientific advances in understanding the causes and treatment of human
malignancy, a persistent challenge facing basic and clinical investigators is how to …

Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

RWF van Leeuwen, T van Gelder… - The Lancet …, 2014 - thelancet.com
In the past decade, many tyrosine-kinase inhibitors have been introduced in oncology and
haemato-oncology. Because this new class of drugs is extensively used, serious drug–drug …